Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $7.1800 (-2.51%) ($7.1750 - $7.1800) on Mon. Feb. 13, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5% (three month average) | RSI | 43 | Latest Price | $7.1800(-2.51%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -2.7% a day on average for past five trading days. | Weekly Trend | IOVA declines -1.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) XBI(50%) IBB(37%) IWC(29%) ARKG(28%) ARKK(26%) | Factors Impacting IOVA price | IOVA will decline at least -2.5% in a week (0% probabilities). VIXM(-14%) BND(-11%) UUP(-9%) XLP(-8%) USO(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.5% (StdDev 5%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
Resistance Level | $7.5 | 5 Day Moving Average | $7.61(-5.65%) | 10 Day Moving Average | $7.81(-8.07%) | 20 Day Moving Average | $7.5(-4.27%) | To recent high | -12.9% | To recent low | 28% | Market Cap | $1.051b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |